GlaxoSmithKline-backed Atreca has now raised $91m in total and will use the series B proceeds to advance a pipeline of therapeutics based on human immune responses.

University of Minnesota has revealed it launched 18 spinouts during the past financial year, putting the total number at 119.

Ankon Technologies, developer of a capsule-based gastric cancer diagnostics system, has received funding from investors including SoftBank's Chinese CVC subsidiary.

The Eli Lilly-backed firm has closed its oversubscribed fourth fund, LAV Biosciences Fund IV, reportedly raising the capital in only two months.

Gene therapy developer Krystal has received $7m in funding from Sun Pharmaceutical Industries, in a deal that values the startup at roughly $44m.

Hong Kong X Technology Fund was established to support participants in an accelerator co-founded by professors from HKUST and University of Hong Kong.

The BioMerieux and Stratec-backed medical diagnostics technology provider has raised $8.5m in a T.Rowe Price-led private placement that will be added to a $46m series D round.

Cuorips, a spinout from Osaka University, has sold an option right for the commercialisation of a treatment for severe heart failure to Daiichi Sankyo in return for an undisclosed sum.